OBI — Ondine Biomedical Share News
0.000.00%
- £39.06m
- £37.65m
- CA$1.20m
RCS - Ondine Biomedical - Steriwave now available through NHS Supply Chain
AnnouncementREG - Ondine Biomedical - 2023 Full Year Results and Annual Report
AnnouncementREG - Ondine Biomedical - Notice of AGM and Directorate Change
AnnouncementREG - Ondine Biomedical - Notice of Results, Investor Presentation, and AGM
AnnouncementREG - Ondine Biomedical - NOTIFICATION OF MAJOR HOLDINGS
AnnouncementRCS - Ondine Biomedical - ECDC report shows rising HAIs and antibiotic use
AnnouncementREG - AIM - AIM Notice - 09/05/2024
AnnouncementREG - Ondine Biomedical - Further Result of Fundraising
AnnouncementREG - Ondine Biomedical - Result of Fundraising
AnnouncementREG - Ondine Biomedical - Ondine announces proposed fundraising
AnnouncementREG - Ondine Biomedical - Related Party Transactions
AnnouncementRCS - Ondine Biomedical - New study confirms nose is key source of infection
AnnouncementREG - Ondine Biomedical - Corporate and Trading Update
AnnouncementRCS - Ondine Biomedical - Steriwave in first Australian hospital
AnnouncementRCS - Ondine Biomedical - 32% Fewer SSIs After Steriwave Replaced Mupirocin
AnnouncementRCS - Ondine Biomedical - Steriwave authorized for use by HCA UK
AnnouncementRCS - Ondine Biomedical - Entry into ICU market expands revenue potential
AnnouncementREG - Ondine Biomedical - Appointment of Interim Chief Financial Officer
AnnouncementREG - Ondine Biomedical - First commercial adoption of Steriwave by the NHS
Announcement